News

The investigational PET tracer iodine-124 (I-124) evuzamitide met its primary endpoints for the diagnosis of cardiac amyloidosis, including transthyretin-mediated…

Background: Transthyretin amyloid cardiomyopathy (ATTR-CM) is an infiltrative cardiomyopathy that may occur in hereditary or wild-type forms. Although more than 150…

The association between amyloidosis and aortic valve stenosis has attracted considerable international attention. However, when researchers at Umeå University…

A new diagnostic tool developed at the University of Tennessee Health Sciences may soon make it significantly easier for physicians to detect cardiac amyloidosis, a…

BridgeBio Pharma is teaming up with BlackDoctor and HealthyWomen to highlight how the heart condition ATTR-cardiac amyloidosis (ATTR-CM) is being “systematically…

AbstractSystemic amyloid light-chain (AL) amyloidosis is characterized by the extracellular deposition of misfolded immunoglobulin light chains in tissues and is…

Differences versus placebo seen within 30 days, sustained to 30 monthsNew analyses suggest Attruby (acoramidis) may reduce the risk of outpatient worsening heart…

73% of Respondents Had Never Heard of ATTR-CM, a Serious Heart Condition Where Women Face Later Diagnosis, Lower Treatment Rates, And Worse Outcomes CHICAGO,…

Cardiac amyloidosis on nuclear imaging of the heart using 11C-PiB PET/CT. Image courtesy of RSNACardiac amyloidosis research is a growing area in cardiology thanks…

Transthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as a significant yet frequently overlooked etiology of heart failure, particularly within the elderly…